HONG KONG SAR - EQS Newswire - 24 November 2025 - Uni-Bio Science Group Limited ("Uni-Bio" or "the Group") recently announced its official entry into a new phase of strategic development. Over the past few years, amidst profound biopharmaceutical industry transformation and multiple market challenges, the Group has consistently adhered to stable operations as its core focus, building financial resilience and commercialization capabilities.